Target intelligence / Profile preview

Biological membrane and lipid interface

Molecular classification
Lipid, Cellular structure, Non-protein target
01

Overview

Biological membranes and lipid interfaces are fundamental structural components of all living cells, primarily composed of a phospholipid bilayer interspersed with cholesterol, glycolipids, and proteins. While traditional pharmacology focuses on protein-specific receptors, many therapeutic agents exert their effects by interacting directly with the lipid environment to alter membrane fluidity, permeability, or integrity (Source: Nature Reviews Drug Discovery). This target is particularly significant in the development of antimicrobial and antifungal therapies, where drugs like polymyxins or amphotericin B disrupt the physical structure of the pathogen's membrane to induce cell death (Source: StatPearls). Additionally, the lipid interface serves as a critical site for the localization of signaling molecules and the fusion of viral particles with host cells. Understanding these non-specific interactions is vital for addressing drug resistance and improving the delivery of lipophilic compounds. However, the lack of high specificity for pathogen versus host membranes often results in a narrow therapeutic index and potential toxicity (Source: Journal of Biological Chemistry).

Other names
Lipid bilayerPlasma membraneCell membranePhospholipid interfaceMembrane lipidsCytoplasmic membrane
02

Mechanism of action

Membrane disruption, pore formation, alteration of membrane curvature, depolarization of the membrane potential, and physical surfactant action (Source: PubMed, NIH).

03

Biological functions

Cellular compartmentalizationSelective permeability and transportSignal transduction platformCell-cell recognitionEnergy transductionMaintenance of electrochemical gradients
04

Disease associations

Bacterial infectionFungal infectionViral entry and replicationCancer (altered membrane lipid composition)Neurodegenerative disease (lipid peroxidation)Respiratory distress syndrome
05

Safety considerations

Hemolysis (destruction of red blood cells)Nephrotoxicity (common with membrane-active antibiotics)NeurotoxicityLack of selectivity between pathogen and host membranesSystemic toxicity due to non-specific binding
06

Interacting drugs

Daptomycin

7 more in the full profile.

07

Biomarkers

Lactate dehydrogenase release (cell membrane integrity marker)Malondialdehyde (lipid peroxidation marker)Propidium iodide uptake (membrane permeability)Phospholipid profile analysisC-reactive protein (systemic inflammation from membrane damage)

Beyond the preview

Go deeper on Biological membrane and lipid interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological membrane and lipid interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call